| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |